{"prompt": "['Horizon Pharma USA, Inc.', 'Teprotumumab (HZN-001) IND: 112952', 'Date: 31 January 2019', 'Protocol: HZNP-TEP-301', 'Version 4.0, incorporating Amendment 3', 'Administer study drug and record date, volume and rate of infusion, and start/stop times', 'of dosing.', 'Subjects will be discharged from the study center after all of the procedures have been completed', 'and will be contacted the following day to enquire about AEs and concomitant medication use.', '9.5.7.5 Week 4', 'Collect blood samples for hematology and glucose testing (see Section 9.5.5.7 for details', 'concerning test results and study participation).', 'Collect blood sample for PK analyses. Record date/time of sample collection.', 'Collect vital signs.', 'Enquire about AEs and concomitant medication use.', 'Subjects will be released from the study center after all of the visit procedures have been', 'completed and instructed to return to the clinic at Week 6.', '9.5.7.6 Week 6', 'Obtain predose blood samples for hematology and chemistry (including thyroid, glucose,', 'but not HbA1c) analysis (see Section 9.5.5.7 for details concerning test results and study', 'participation).', 'Collect predose urine sample for urinalysis and also for a pregnancy test for females of', 'childbearing potential; the pregnancy test must be negative for the subject to receive', 'study drug.', 'Enquire about signs and symptoms and concomitant medications throughout the visit.', 'Perform predose 12-lead ECG.', 'Perform predose physical and ophthalmic examinations, including vital signs. Additional', 'vital sign monitoring may be performed in the event of infusion-associated AEs (see', 'Section 9.5.5.4 for details).', 'Perform predose efficacy assessments (CAS, Clinical Measures of Severity including', 'proptosis, diplopia and motility restriction).', 'Administer predose GO-QoL questionnaire.', 'Contact IWRS to obtain study medication vial assignment and to determine the volume', 'of study drug to be administered.', 'PRIVATE AND CONFIDENTIAL INFORMATION OF HORIZON PHARMA USA, INC', 'Page 95 of 117']['Horizon Pharma USA, Inc.', 'Teprotumumab (HZN-001) IND: 112952', 'Date: 31 January 2019', 'Protocol: HZNP-TEP-301', 'Version 4.0, incorporating Amendment 3', 'Administer study drug and record date, volume and rate of infusion, and start/stop times', 'of dosing.', 'Subjects will be discharged from the study center after all of the procedures have been completed', 'and instructed to return for a clinic visit at Week 9.', '9.5.7.7 Week 9', 'Obtain predose blood samples for hematology and chemistry (including thyroid, glucose,', 'but not HbA1c) analysis (see Section 9.5.5.7 for details concerning test results and study', 'participation).', 'Collect predose urine sample for urinalysis and also for a pregnancy test for females of', 'childbearing potential; the pregnancy test must be negative for the subject to receive', 'study drug.', 'Collect predose blood samples for immunogenicity testing.', 'Enquire about signs and symptoms and concomitant medications throughout the visit.', 'Collect predose vital signs. Additional vital sign monitoring may be performed in the', 'event of infusion-associated AEs (see Section 9.5.5.4 for details).', 'Collect blood samples for PK analyses prior to and at the end of the infusion.', 'Contact IWRS to obtain study medication vial assignment and to determine the volume', 'of study drug to be administered.', 'Administer study drug and record date, volume and rate of infusion, and start/stop times', 'of dosing.', 'Subjects will be discharged from the study center after all of the procedures have been completed', 'and instructed to return for a clinic visit at Week 12.', '9.5.7.8 Week 12', 'Obtain predose blood samples for hematology and chemistry (including thyroid, glucose,', 'and HbA1c) analysis (see Section 9.5.5.7 for details concerning test results and study', 'participation).', 'Collect predose urine sample for urinalysis and also for a pregnancy test for females of', 'childbearing potential; the pregnancy test must be negative for the subject to receive', 'study drug.', 'Collect predose blood samples for biomarker analyses.', 'Enquire about signs and symptoms and concomitant medications throughout the visit.', 'PRIVATE AND CONFIDENTIAL INFORMATION OF HORIZON PHARMA USA, INC', 'Page 96 of 117']\n\n###\n\n", "completion": "END"}